Search results
Daphne Koller is CEO and Founder of insitro, a machine learning-enabled drug discovery company. She is also co-founder of Engageli, a digital learning plat...
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients.
Daphne Koller is the CEO and founder of insitro, a machine learning–enabled drug discovery company. Daphne is also the co-founder of Engageli, was the Rajeev...
Feb 20, 2013 · This former Stanford University professor’s cutting edge work combines machine learning and biology to transform pharmaceutical drug development. Her work at...
View Daphne Koller’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- 15K
- insitro
- San Francisco Bay Area
Nov 11, 2019 · Daphne Koller, A Star Professor—And Her Radical, AI-Powered Plan To Discover New Drugs ... Join Us; info@insitro.com. 279 East Grand Avenue South San Francisco ...
Oct 25, 2023 · Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI technology is able to analyze images of cancerous tissue, a ...